WebApr 11, 2024 · GeneThera, Inc. is a biotechnology company that focuses on eradicating zoonotic diseases such as COVID-19 (Novel Coronavirus), Paratuberculosis (Johne’s … WebJan 25, 2012 · WESTMINSTER, Colo., Jan. 25, 2012 /PRNewswire/ -- GeneThera, Inc. (OTCQB: GTHR) announced today that it has acquired a majority ownership of Applied Genetics, a molecular diagnostic company based ...
GeneThera Technology Platform for Wastewater Testing: A More ... - BioSpace
WebOct 12, 2024 · GeneThera, Inc. announced that it has entered into an exclusive agreement with Cushman & Wakefield to identify land sites and warehouse buildings in the Denver area in connection with the development of GeneThera Zoonotic Disease Alert Shield (ZIDAS) surveillance network. While the Stationary BSL3 laboratory is built, the Company … WebMar 24, 2024 · Latest GeneThera, Inc. Stock News. As of March 24, 2024, GeneThera, Inc. had a $0.3 million market capitalization, putting it in the 1st percentile of companies in the Biotechnology & Medical Research industry. GeneThera, Inc. does not have a meaningful P/E due to negative earnings over the last 12 trailing months. new home good wishes
GENETHERA INC : MANAGEMENT
WebAug 16, 2024 · When we are able to develop assays for different diseases, we intend to formalize the procedure into a commercial application through a series of laboratories to be owned and operated by GeneThera. To date, we have introduced our diagnostic solution for Chronic Wasting Disease (CWD) and Mad Cow Disease on a very limited basis. WebApr 6, 2024 · GeneThera developed molecular assays for BSE and Mycobacterium Avium Paratuberculosis (MAP). MAP is an infectious organism causing Paratuberculosis in dairy cows that is also linked to Crohn’s ... http://genetherainc.com/ in that quiet earth villa price